ABI
Adamant Biomedical Investments Portfolio holdings
AUM
$418M
This Quarter Return
+10.95%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$418M
AUM Growth
+$418M
(+4.4%)
Cap. Flow
-$21.3M
Cap. Flow
% of AUM
-5.1%
Top 10 Holdings %
Top 10 Hldgs %
32.81%
Holding
108
New
12
Increased
10
Reduced
35
Closed
7
Top Buys
| 1 |
HSP
HOSPIRA INC
HSP
|
$5.51M |
| 2 |
Acadia Pharmaceuticals
ACAD
|
$5.4M |
| 3 |
WX
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
|
$4.71M |
| 4 |
MDVN
MEDIVATION, INC.
MDVN
|
$4.48M |
| 5 |
Ligand Pharmaceuticals
LGND
|
$4.33M |
Top Sells
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
$5.12M |
| 2 |
ProShares Ultra NASDAQ Biotechnology
BIB
|
$4.39M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$4.03M |
| 4 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
$3.82M |
| 5 |
QGENF
QIAGEN NV
QGENF
|
$3.53M |
Sector Composition
| 1 | Healthcare | 87.28% |
| 2 | Financials | 0.93% |
| 3 | Industrials | 0.35% |
| 4 | Technology | 0.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Centene
CNC
$14.5B
| $5.36M | 1.28% |
51,610
-26,850
| -34% | -$2.79M |
|
|
SLXP
27
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $5.17M | 1.24% |
45,000
-33,210
| -42% | -$3.82M |
|
28
Cigna
CI
$80.3B
| $5.15M | 1.23% |
50,000
| – | – |
|
29
Incyte
INCY
$16.8B
| $5.12M | 1.22% |
70,000
| – | – |
|
30
Molina Healthcare
MOH
$9.93B
| $4.91M | 1.17% |
91,710
-39,340
| -30% | -$2.11M |
|
|
ESRX
31
DELISTED
Express Scripts Holding Company
ESRX
| $4.83M | 1.15% |
57,000
| – | – |
|
32
Baxter International
BAX
$12.4B
| $4.76M | 1.14% |
65,000
| – | – |
|
33
Brookdale Senior Living
BKD
$1.83B
| $4.75M | 1.14% |
129,540
-8,080
| -6% | -$296K |
|
|
WX
34
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
| $4.71M | 1.13% |
+140,000
| New | +$4.71M |
|
|
35
Ligand Pharmaceuticals
LGND
$3.19B
| $4.33M | 1.03% |
+81,280
| New | +$4.33M |
|
36
Humana
HUM
$37.3B
| $4.31M | 1.03% |
30,000
-5,000
| -14% | -$718K |
|
37
Johnson & Johnson
JNJ
$429B
| $4.18M | 1% |
40,000
-5,000
| -11% | -$523K |
|
|
LCI
38
DELISTED
Lannett Company, Inc.
LCI
| $4.04M | 0.97% |
94,210
+14,210
| +18% | +$609K |
|
39
HCA Healthcare
HCA
$95B
| $4.04M | 0.96% |
55,000
+10,000
| +22% | +$734K |
|
40
AbbVie
ABBV
$374B
| $3.93M | 0.94% |
+60,000
| New | +$3.93M |
|
41
Stryker
SYK
$149B
| $3.92M | 0.94% |
41,500
-16,000
| -28% | -$1.51M |
|
|
AET
42
DELISTED
Aetna Inc
AET
| $3.91M | 0.93% |
44,000
-16,000
| -27% | -$1.42M |
|
43
Elevance Health
ELV
$72.6B
| $3.77M | 0.9% |
30,000
-8,000
| -21% | -$1.01M |
|
44
Bristol-Myers Squibb
BMY
$96.5B
| $3.54M | 0.85% |
60,000
+10,000
| +20% | +$590K |
|
45
Perrigo
PRGO
$3.23B
| $3.33M | 0.8% |
20,000
-10,750
| -35% | -$1.79M |
|
|
STJ
46
DELISTED
St Jude Medical
STJ
| $3.32M | 0.79% |
51,000
-14,000
| -22% | -$911K |
|
47
Jazz Pharmaceuticals
JAZZ
$7.87B
| $3.28M | 0.78% |
20,000
| – | – |
|
48
BioMarin Pharmaceuticals
BMRN
$11.3B
| $3.25M | 0.78% |
36,000
-14,000
| -28% | -$1.27M |
|
49
CVS Health
CVS
$94B
| $2.89M | 0.69% |
30,000
-15,000
| -33% | -$1.44M |
|
|
ENDP
50
DELISTED
Endo International plc
ENDP
| $2.89M | 0.69% |
40,000
| – | – |
|